Retrospektive Untersuchung der Anti-VEGF-Behandlungsrealität und Wirksamkeit bei Patienten mit neovaskulärer altersabhängiger Makuladegeneration (nAMD) in Deutschland
作者： F. Ziemssen , , N. Eter , S. Fauser , S. Bopp
DOI: 10.1007/S00347-014-3217-7
关键词:
摘要: Hintergrund Es gibt noch wenig aktuelle deutsche Daten, die beschreiben, wie Standardtherapie der neovaskularen altersabhangigen Makuladegeneration (nAMD), intravitreale operative Medikamentengabe (IVOM) von Vascular-endothelial-growth-factor (VEGF)-Inhibitoren, im klinischen Alltag umgesetzt wird.
springer.com
sci-hub.se 参考文章(14)
David S Friedman, Benita J O’Colmain, Beatriz Munoz, Sandra C Tomany, Cathy McCarty, PT De Jong, Barbara Nemesure, Paul Mitchell, John Kempen, None, Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology. ,vol. 122, pp. 564- 572 ,(2004) , 10.1001/ARCHOPHT.122.4.564
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris 3rd, Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, None, Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. ,vol. 119, pp. 1388- 1398 ,(2012) , 10.1016/J.OPHTHA.2012.03.053
Salomon Y. Cohen, Gerard Mimoun, Hassiba Oubraham, Alain Zourdani, Christian Malbrel, Stephane Queré, Véronique Schneider, Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 33, pp. 474- 481 ,(2013) , 10.1097/IAE.0B013E31827B6324
Robert P. Finger, Peter Wiedemann, Francisca Blumhagen, Karin Pohl, Frank G. Holz, Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany Acta Ophthalmologica. ,vol. 91, pp. 540- 546 ,(2013) , 10.1111/J.1755-3768.2012.02493.X
Philipp S. Muether, Robert Hoerster, Manuel M. Hermann, Bernd Kirchhof, Sascha Fauser, Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 251, pp. 453- 458 ,(2013) , 10.1007/S00417-012-2038-0
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy, Tsontcho Ianchulev, None, Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study Ophthalmology. ,vol. 116, pp. 57- 65 ,(2009) , 10.1016/J.OPHTHA.2008.10.018
Elena Prokofyeva, Eberhart Zrenner, Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Research. ,vol. 47, pp. 171- 188 ,(2012) , 10.1159/000329603
Cristina A. Augood, Prevalence of Age-Related Maculopathy in Older Europeans Archives of Ophthalmology. ,vol. 124, pp. 529- 535 ,(2006) , 10.1001/ARCHOPHT.124.4.529
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim, None, Ranibizumab for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 355, pp. 1419- 1431 ,(2006) , 10.1056/NEJMOA054481
Frank G Holz, Ramin Tadayoni, Stephen Beatty, Alan Berger, Matteo G Cereda, Rafael Cortez, Carel B Hoyng, Philip Hykin, Giovanni Staurenghi, Stephanie Heldner, Timon Bogumil, Theresa Heah, Sobha Sivaprasad, None, Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration British Journal of Ophthalmology. ,vol. 99, pp. 220- 226 ,(2015) , 10.1136/BJOPHTHALMOL-2014-305327